𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Does hormone replacement therapy and use of oral contraceptives increase the risk of non-melanoma skin cancer?

✍ Scribed by Fatima Birch-Johansen; Allan Jensen; Anne Braae Olesen; Jane Christensen; Anne Tjønneland; Susanne K. Kjær

Publisher
Springer Netherlands
Year
2012
Tongue
English
Weight
223 KB
Volume
23
Category
Article
ISSN
0957-5243

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral contraceptive use, hormone replacem
Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women
✍ Geoffrey C. Kabat; Anthony B. Miller; Thomas E. Rohan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 2 views

## Abstract Evidence from epidemiologic studies suggests a possible role of exogenous and endogenous hormones in colorectal carcinogenesis in women. However, with respect to exogenous hormones, in contrast to hormone replacement therapy, few cohort studies have examined oral contraceptive use in re

Hormone replacement therapy and breast c
Hormone replacement therapy and breast cancer in former users of oral contraceptives—The Norwegian Women and Cancer study
✍ Eiliv Lund; Kjersti Bakken; Vanessa Dumeaux; Vegard Andersen; Merethe Kumle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 66 KB 👁 2 views

## Abstract Combined estrogen–progestin menopausal therapy (HRT) and combined estrogen–progestin contraceptives (OC) both increase breast cancer risk during current use and a few years after. We investigated risk of breast cancer in women who were users of HRT dependant on former history of OC use

Oral contraceptives, menopausal hormone
Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study
✍ Yani Lu; Sophia S. Wang; Jane Sullivan-Halley; Ellen T. Chang; Christina A. Clar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 140 KB 👁 1 views

We examined oral contraceptive (OC) and menopausal hormonal therapy (MHT) use in relation to risk of B-cell non-Hodgkin lymphoma (NHL). Women under age 85 years participating in the California Teachers Study with no history of hematopoietic cancer were followed from 1995 through 2007. A total of 516